Serum PTH reference values established by an automated third-generation assay in Vitamin D-replete subjects with normal renal function: Consequences of diagnosing primary hyperparathyroidism and the classification of dialysis patients

European Journal of Endocrinology

Volumn 174, Issue 3, 2016, Pages 315-323

  Souberbielle, Jean Claude ^a   Massart, Catherine ^b   Brailly Tabard, Sylvie ^c,d,e   Cormier, Catherine ^f   Cavalier, Etienne ^g   Delanaye, Pierre ^g   Chanson, Philippe ^h,i  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^c Service de Genetique Moleculaire Pharmacogenetique et Hormonologie   (France)

^d UNIVERSITÉ PARIS SACLAY   (France)

^e INSERM   (France)

^f Institut Cochin   (France)

^g UNIVERSITY OF LIÈGE   (Belgium)

^h BICÊTRE HOSPITAL   (France)

ⁱ Bicêtre Paris Saclay Hospital   (France)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; PARATHYROID HORMONE; 25-HYDROXYVITAMIN D; VITAMIN D;

ADULT; AGE; AGED; ARTICLE; AUTOMATION; BODY MASS; CALCIUM BLOOD LEVEL; CONCENTRATION (PARAMETERS); FEMALE; FRENCHMAN; GENDER; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HORMONE DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PARATHYROID HORMONE BLOOD LEVEL; PATIENT CODING; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; REFERENCE VALUE; SENSITIVITY ANALYSIS; VITAMIN BLOOD LEVEL; ADOLESCENT; ANALOGS AND DERIVATIVES; BLOOD; CASE CONTROL STUDY; COMPLICATION; HYPERPARATHYROIDISM, PRIMARY; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; RENAL REPLACEMENT THERAPY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; CASE-CONTROL STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERPARATHYROIDISM, PRIMARY; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PARATHYROID HORMONE; REFERENCE VALUES; RENAL DIALYSIS; VITAMIN D; YOUNG ADULT;

EID: 84958280754     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-15-0595     Document Type: Article

References (34)

1. Cavalier E, Daly AF, Betea D, Pruteanu-Apetrii PN, Delanaye P, Stubbs P, Bradwell AR, Chapelle JP & Beckers A. The ratio of parathyroid hormone as measured by third-and second-generation assays as a marker for parathyroid carcinoma. Journal of Clinical Endocrinology and Metabolism 2010 95 3745-3749. (doi:10.1210/jc.2009-2791)
2. Souberbielle JC, Cavalier E & Jean G. Interpretation of serum parathyroid hormone concentrations in dialysis patients: what do the KDIGO guidelines change for the clinical laboratory? Clinical Chemistry and Laboratory Medicine 2010 48 769-774. (doi:10.1515/CCLM.2010.157)
3. Eastell R, Brandi ML, Costa AG, D'Amour P, Shoback DM & Thakker RV. Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. Journal of Clinical Endocrinology and Metabolism 2014 99 3570-3579. (doi:10.1210/jc.2014-1414)
4. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney International. Supplement, 2009 S1-S130. (doi:10.1038/ki.2009.188)
5. Cusano NE, Silverberg SJ & Bilezikian JP. Normocalcemic primary hyperparathyroidism. Journal of Clinical Densitometry 2013 16 33-39. (doi:10.1016/j.jocd.2012.12.001)
6. Touvier M, Deschasaux M, Montourcy M, Sutton A, Charnaux N, Kesse-Guyot E, Fezeu LK, Latino-Martel P, Druesne-Pecollo N, Malvy D et al. Interpretation of plasma PTH concentrations according to 25OHD status, gender, age, weight status, and calcium intake: importance of the reference values. Journal of Clinical Endocrinology and Metabolism 2014 99 1196-1203. (doi:10.1210/jc.2013-3349)
7. Bilezikian JP, Brandi ML, Eastell R, Silverberg SJ, Udelsman R, Marcocci C & Potts JT Jr. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. Journal of Clinical Endocrinology and Metabolism 2014 99 3561-3569. (doi:10.1210/jc.2014-1413)
8. Eastell R, Arnold A, Brandi ML, Brown EM, D'Amour P, Hanley DA, Rao DS, Rubin MR, Goltzman D, Silverberg SJ et al. Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the Third International Workshop. Journal of Clinical Endocrinology and Metabolism 2009 94 340-350. (doi:10.1210/jc.2008-1758)
9. Cavalier E, Delanaye P, Vranken L, Bekaert AC, Carlisi A, Chapelle JP & Souberbielle JC. Interpretation of serum PTH concentrations with different kits in dialysis patients according to the KDIGO guidelines: importance of the reference (normal) values. Nephrology, Dialysis, Transplantation 2012 27 1950-1956. (doi:10.1093/ndt/gfr535)
10. Djennane M, Lebbah S, Roux C, Djoudi H, Cavalier E & Souberbielle JC. Vitamin D status of schoolchildren in Northern Algeria, seasonal variations and determinants of vitamin D deficiency. Osteoporosis International 2014 25 1493-1502. (doi:10.1007/s00198-014-2623-7)
11. Souberbielle JC, Cormier C, Kindermans C, Gao P, Cantor T, Forette F & Baulieu EE. Vitamin D status and redefining serum parathyroid hormone reference range in the elderly. Journal of Clinical Endocrinology and Metabolism 2001 86 3086-3090.
12. Souberbielle JC, Fayol V, Sault C, Lawson-Body E, Kahan A & Cormier C. Assay-specific decision limits for two new automated parathyroid hormone and 25-hydroxyvitamin D assays. Clinical Chemistry 2005 51 395-400. (doi:10.1373/clinchem.2004.037606)
13. Koumakis E, Souberbielle JC, Sarfati E, Meunier M, Maury E, Gallimard E, Borderie D, Kahan A & Cormier C. Bone mineral density evolution after successful parathyroidectomy in patients with normo-calcemic primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism 2013 98 3213-3220. (doi:10.1210/jc.2013-1518)
14. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF III, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T et al. A new equation to estimate glomerular filtration rate. Annals of Internal Medicine 2009 150 604-612. (doi:10.7326/0003-4819-150-9-200905050-00006)
15. Horn PS, Feng L, Li Y & Pesce AJ. Effect of outliers and nonhealthy individuals on reference interval estimation. Clinical Chemistry 2001 47 2137-2145.
16. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. Journal of Clinical Endocrinology and Metabolism 2011 96 53-58. (doi:10.1210/jc.2010-2704)
17. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM & Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism 2011 96 1911-1930. (doi:10.1210/jc.2011-0385)
18. Brouwer-Brolsma EM, Bischoff-Ferrari HA, Bouillon R, Feskens EJ, Gallagher CJ, Hypponen E, Llewellyn DJ, Stoecklin E, Dierkes J, Kies AK et al. Vitamin D: do we get enough? A discussion between vitamin D experts in order to make a step towards the harmonisation of dietary reference intakes for vitamin D across Europe Osteoporosis International 2013 24 1567-1577. (doi:10.1007/s00198-012-2231-3)
19. Bruyere O, Cavalier E, Souberbielle JC, Bischoff-Ferrari HA, Beaudart C, Buckinx F, Reginster JY & Rizzoli R. Effects of vitamin D in the elderly population: current status and perspectives. Archives of Public Health 2014 72 32. (doi:10.1186/2049-3258-72-32)
20. Bouillon R, Van Schoor NM, Gielen E, Boonen S, Mathieu C, Vanderschueren D& Lips P. Optimal vitamin D status: a critical analysis on the basis of evidence-based medicine. Journal of Clinical Endocrinology and Metabolism 2013 98 E1283-E1304. (doi:10.1210/jc.2013-1195)
21. Maeda SS, Borba VZ, Camargo MB, Silva DM, Borges JL, Bandeira F & Lazaretti-Castro M. Recommendations of the Brazilian Society of Endocrinology and Metabology (SBEM) for the diagnosis and treatment of hypovitaminosis D. Arquivos Brasileiros de Endocrinologia e Metabologia 2014 58 411-433. (doi:10.1590/0004-2730000003388)
22. Bjorkman M, Sorva A & Tilvis R. Responses of parathyroid hormone to vitamin D supplementation: a systematic review of clinical trials. Archives of Gerontology and Geriatrics 2009 48 160-166. (doi:10.1016/j. archger.2007.12.005)
23. Bell NH, Greene A, Epstein S, Oexmann MJ, Shaw S & Shary J. Evidence for alteration of the vitamin D-endocrine system in blacks. Journal of Clinical Investigation 1985 76 470-473. (doi:10.1172/JCI111995)
24. Bellia A, Marinoni G, D'Adamo M, Guglielmi V, Lombardo M, Donadel G, Gentileschi P, Lauro D, Federici M, Lauro R et al. Parathyroid hormone and insulin resistance in distinct phenotypes of severe obesity: a cross-sectional analysis in middle-aged men and premenopausal women. Journal of Clinical Endocrinology and Metabolism 2012 97 4724-4732. (doi:10.1210/jc.2012-2513)
25. Quesada JM, Coopmans W, Ruiz B, Aljama P, Jans I & Bouillon R. Influence of vitamin D on parathyroid function in the elderly. Journal of Clinical Endocrinology and Metabolism 1992 75 494-501.
26. Ong GS, Walsh JP, Stuckey BG, Brown SJ, Rossi E, Ng JL, Nguyen HH, Kent GN & Lim EM. The importance of measuring ionized calcium in characterizing calcium status and diagnosing primary hyperparathy-roidism. Journal of Clinical Endocrinology and Metabolism 2012 97 3138-3145. (doi:10.1210/jc.2012-1429)
27. Souberbielle JC, Lawson-Body E, Hammadi B, Sarfati E, Kahan A & Cormier C. The use in clinical practice of parathyroid hormone normative values established in vitamin D-sufficient subjects. Journal of Clinical Endocrinology and Metabolism 2003 88 3501-3504. (doi:10.1210/jc.2003-030097)
28. Cantor T, Yang Z, Caraiani N & Ilamathi E. Lack of comparability of intact parathyroid hormone measurements among commercial assays for end-stage renal disease patients: implication for treatment decisions. Clinical Chemistry 2006 52 1771-1776. (doi:10.1373/clinchem.2006.071589)
29. Joly D, Drueke TB, Alberti C, Houillier P, Lawson-Body E, Martin KJ, Massart C, Moe SM, Monge M & Souberbielle JC. Variation in serum and plasma PTH levels in second-generation assays in hemodialysis patients: a cross-sectional study. American Journal of Kidney Diseases 2008 51 987-995. (doi:10.1053/j.ajkd.2008.01.017)
30. Souberbielle JC, Boutten A, Carlier MC, Chevenne D, Coumaros G, Lawson-Body E, Massart C, Monge M, Myara J, Parent X et al. Inter-method variability in PTH measurement: implication for the care of CKD patients. Kidney International 2006 70 345-350. (doi:10.1038/sj.ki.5001606)
31. Barreto FC, Barreto DV, Moyses RM, Neves KR, Canziani ME, Draibe SA, Jorgetti V & Carvalho AB. K/DOQI-recommended intact PTH levels do not prevent low-turnover bone disease in hemodialysis patients. Kidney International 2008 73 771-777. (doi:10.1038/sj.ki.5002769)
32. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG & Chertow GM. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. Journal of the American Society of Nephrology 2004 15 2208-2218. (doi:10.1097/01.ASN.0000133041.27682.A2)
33. Kalantar-Zadeh K, Kuwae N, Regidor DL, Kovesdy CP, Kilpatrick RD, Shinaberger CS, McAllister CJ, Budoff MJ, Salusky IB & Kopple JD. Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney International 2006 70 771-780. (doi:10.1038/sj.ki.5001514)
34. Rejnmark L, Vestergaard P, Heickendorff L & Mosekilde L. Determinants of plasma PTH and their implication for defining a reference interval. Clinical Endocrinology 2011 74 37-43. (doi:10.1111/j.1365-2265.2010.03894.x)